Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SPFPL DOCTEUR BAUMONT : revenue, balance sheet and financial ratios

SPFPL DOCTEUR BAUMONT is a French company founded 4 years ago, specialized in the sector Fonds de placement et entités financières similaires. Based in SAINT-DENIS (97400), this company of category PME shows in 2025 a net income positive of 1.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SPFPL DOCTEUR BAUMONT (SIREN 908652050)
Indicator 2025 2024 2023 2022
Revenue N/C N/C N/C N/C
Net income 1 017 828 € 1 195 765 € 1 120 513 € 749 536 €
EBITDA -6 875 € -6 437 € -25 042 € -210 086 €
Net margin N/C N/C N/C N/C

Revenue and income statement

In 2025, SPFPL DOCTEUR BAUMONT generates positive net income of 1.0 M€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2022-2025: 750 k€ -> 1.0 M€.

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-6 875 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-28 900 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

1 017 828 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 100%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.0 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.463%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

99.539%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.019

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

2.8%

Solvency indicators evolution
SPFPL DOCTEUR BAUMONT

Sector positioning

Debt ratio
0.46 2025
2023
2024
2025
Q1: 0.14
Med: 27.24
Q3: 146.28
Good -16 pts over 3 years

In 2025, the debt ratio of SPFPL DOCTEUR BAUMONT (0.46) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
99.54% 2025
2023
2024
2025
Q1: 17.38%
Med: 54.75%
Q3: 87.41%
Excellent

In 2025, the financial autonomy of SPFPL DOCTEUR BAUMONT (99.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.02 years 2025
2023
2024
2025
Q1: 0.0 years
Med: 0.77 years
Q3: 6.12 years
Good -25 pts over 3 years

In 2025, the repayment capacity of SPFPL DOCTEUR BAUMONT (0.02) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Positioning of SPFPL DOCTEUR BAUMONT in its sector

Comparison with sector Fonds de placement et entités financières similaires

Valuation estimate

Based on 170 transactions of similar company sales (all years), the value of SPFPL DOCTEUR BAUMONT is estimated at 10 551 621 € (range 6 540 470€ - 16 411 093€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
170 transactions
6540k€ 10551k€ 16411k€
10 551 621 € Range: 6 540 470€ - 16 411 093€
NAF 5 all-time

Valuation method used

Net Income Multiple
1 017 828 € × 10.4x = 10 551 621 €
Range: 6 540 470€ - 16 411 093€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 170 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fonds de placement et entités financières similaires)

Compare SPFPL DOCTEUR BAUMONT with other companies in the same sector:

Voir toutes les statistiques du secteur Fonds de placement et entités financières similaires

Frequently asked questions about SPFPL DOCTEUR BAUMONT

What is the revenue of SPFPL DOCTEUR BAUMONT ?

The revenue of SPFPL DOCTEUR BAUMONT is not publicly disclosed (confidential accounts filed with INPI).

Is SPFPL DOCTEUR BAUMONT profitable?

Yes, SPFPL DOCTEUR BAUMONT generated a net profit of 1.0 M€ in 2025.

Where is the headquarters of SPFPL DOCTEUR BAUMONT ?

The headquarters of SPFPL DOCTEUR BAUMONT is located in SAINT-DENIS (97400), in the department La Reunion.

Where to find the tax return of SPFPL DOCTEUR BAUMONT ?

The tax return of SPFPL DOCTEUR BAUMONT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SPFPL DOCTEUR BAUMONT operate?

SPFPL DOCTEUR BAUMONT operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.